STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #4038 by analyst upside · 2026-06-27
TDOC
Teladoc Health, Inc.
Healthcare · Market Cap $2B · P/E 0x
ANALYST PRICE TARGET
-11.8%
implied upside to consensus target
Current Price $8.39
Consensus Target $7.4
Bull Target $10.0
Bear Target $5.0
Analysts Covering 20
ANALYST CONSENSUS - HOLD
Strong Buy
1
Buy
5
Hold
15
Sell
0
52-Week Low $4.4
52-Week High $9.77
YTD Return +19.0%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) N/A
Forward P/E -13.0x
EPS (TTM) $-0.97
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $2.5B
Profit Margin -6.8%
52-WEEK RANGE
52-Week Low $4.4
52-Week High $9.77
Current Price $8.39
Bear Target $5.0
Bull Target $10.0
● Now $8.39 ● Target $7.4
TRADING DATA
Avg Volume 4.7M
YTD Return +19.0%
Analyst Count 20
Consensus Hold
Upside to Target -11.8%
Last Updated 2026-06-27

ANALYST SUMMARY

Teladoc Health, Inc. (TDOC) is currently trading at $8.39 with a Wall Street consensus price target of $7.4, which is 11.8% below the current price over the next 12 months. 20 analysts currently cover TDOC, with a consensus rating of Hold - 29% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $10.0, while the most cautious has a target of $5.0.

TDOC operates in the Healthcare sector with a market capitalisation of $2B. The stock is up 19.0% year-to-date and is currently trading near the upper end of its 52-week range of $4.4 – $9.77.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for TDOC, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Citigroup — Reiterated
Neutral → Neutral 2026-05-05 Building track record
Evercore ISI Group — Reiterated
In-Line → In-Line 2026-04-08 Building track record
Barclays — Reiterated
Equal-Weight → Equal-Weight 2026-03-26 Building track record
JP Morgan — Reiterated
Neutral → Neutral 2026-03-13 43% win rate (7 calls)
Deutsche Bank ↑ Upgrade
Hold → Buy 2026-03-10 Building track record
Citigroup — Reiterated
Neutral → Neutral 2026-03-03 Building track record
Oppenheimer — Reiterated
Outperform → Outperform 2026-03-03 14% win rate (7 calls)
Canaccord Genuity — Reiterated
Buy → Buy 2026-02-26 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
43
out of 100
Coverage depth
23/30
Consensus clarity
18/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →